Medtronic Sees Gains In Vascular Unit, Shorter Drug-Coated Stent Timeline

Medtronic does not foresee human clinical trials randomizing their drug-coated stent against an approved commercially available equivalent as necessary for FDA approval.

More from Archive

More from Medtech Insight